首页
订购/客服:400-666-5481

DDO-5936

    
99.20%

DDO-5936

源叶(MedMol)
S89267 一键复制产品信息
2355377-13-6
C25H29N5O4S
495.598
DDO-5936; DDO 5936; DDO5936;N-(Mesitylsulfonyl)-N-(4-((2-(pyrrolidin-1-yl)pyrimidin-4-yl)amino)phenyl)glycine
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S89267-5mg买3赠1
99.20%

¥430.00

5 - - - -
S89267-25mg促销
99.20%

¥820.00 ¥656.00

1 - - - -
S89267-10mg买3赠1
99.20%

¥680.00

6 - - - -
S89267-100mg促销
≥98%

¥2350.00 ¥2110.00

货期:2-3天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: DDO-5936 is a potent and specific Hsp90-Cdc37 PPI inhibitor. DDO-5936 can be used for the research of colorectal cancer
靶点: Hsp90-Cdc37 PPI;HSP
体外研究: DDO-5936 is a Hsp90-Cdc37 PPI inhibitor with potency and specificity through binding to a critical site on Hsp90 involving Glu47
体内研究: DDO-5936 (0~80 mg/kg; p.o.) shows effect at the high dose group. DDO-5936 is well tolerated for the absence of serious weight loss. DDO-5936 high dose groups show that tumor cells in the xenografts decreased significantly. DDO-5936 shows limited oral efficiency. Animal Model: Mice Dosage: 0~80 mg/kg Administration: P.o. Result: Showed a moderate effect at the high dose group.
参考文献: 1. Wang L, et al. Discovery and Optimization of Small Molecules Targeting the Protein-Protein Interaction of Heat Shock Protein 90 (Hsp90) and Cell Division Cycle 37 as Orally Active Inhibitors for the Treatment of Colorectal Cancer. J Med Chem. 2020;63(3):1
溶解性: Soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.018 ml 10.089 ml 20.178 ml
5 mM 0.404 ml 2.018 ml 4.036 ml
10 mM 0.202 ml 1.009 ml 2.018 ml
50 mM 0.04 ml 0.202 ml 0.404 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×